• Trending
  • Latest
    Sign in Sign up
    • Log In
    • Register
    • Home
    • Discover
    • Experts
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Mashup Score: 10
      Uncovering Regulatory Mechanisms of T-cells in Chronic Inflammation - 9 month(s) ago

      Northwestern Medicine scientists have discovered a new underlying mechanisms that controls a specialized group of T-cells, findings that may serve as potential targets for treating inflammatory diseases and cancer, according to a recent study.

      Source: news.feinberg.northwestern.edu
      Categories: General Medicine News, Oncologists1
      Tweet Tweets with this article
      • Profile photo of 	LurieCancer
        LurieCancer

        .@LurieCancer scientists at @NorthwesternMed have discovered a new mechanism that controls regulatory T-cells and may serve as potential therapeutic targets to treat inflammatory diseases and cancer, per a recent study in @ImmunityCP from @minlabFSM. https://t.co/xykXVO0kRu https://t.co/87vv0xwBNk

    • Mashup Score: 13
      Improving Next-Generation Cancer Treatments - 10 month(s) ago

      Northwestern Medicine scientists have developed a more effective method of delivering a cutting-edge cancer treatment, according to findings published in the journal ACS Nano.

      Source: news.feinberg.northwestern.edu
      Categories: General Medicine News, Oncologists1
      Tweet Tweets with this article
      • Profile photo of 	LurieCancer
        LurieCancer

        Lurie Cancer Center scientists at @NorthwesternMed have developed a promising method to enhance the effectiveness of cryo-immunotherapy, according to Dong-Hyun Kim, PhD, senior author of a study in @acsnano. https://t.co/cgVhGNejfh @dhkim0405 #cryoablation #immunotherapy https://t.co/cAXuiXBJ7G

    • Mashup Score: 13
      B-Cells Hold Promise for Treating Glioblastoma - 10 month(s) ago

      Harnessing the body’s own B-cells to fight tumors may be a promising treatment for glioblastoma, according to a Northwestern Medicine study recently published in the Journal of Clinical Investigation.

      Source: news.feinberg.northwestern.edu
      Categories: General Medicine News, Oncologists1
      Tweet Tweets with this article
      • Profile photo of 	LurieCancer
        LurieCancer

        Harnessing the body’s B-cells to fight tumors may be a promising treatment for #glioblastoma, according to a recent study from Lurie Cancer Center member @CatyLeechang published in @jclinicalinvest. https://t.co/kDClMxukKl via @NUFeinbergMed #BTSM

    • Mashup Score: 97
      New Chief of Division of Hematology and Oncology Named - 10 month(s) ago

      Hidayatullah G. Munshi, MD, ‘02, ‘04 GME, has been named chief of Feinberg’s Division of Hematology and Oncology in the Department of Medicine.

      Source: news.feinberg.northwestern.edu
      Categories: General Medicine News, Oncologists1
      Tweet Tweets with this article
      • Profile photo of 	LurieCancer
        LurieCancer

        Congratulations to Lurie Cancer Center’s Hidayatullah Munshi, MD, on being named Chief of the Division of Hematology and Oncology at @NUFeinbergMed! https://t.co/nfZD8djdWe https://t.co/zLLqp8uU3d

    • Mashup Score: 1
      Social Determinants of Health Associated with Diabetic Eye-Care Quality - 10 month(s) ago

      Patients who live in rural communities, Hispanic patients and Black patients with pre-existing diabetic retinopathy are less likely to receive annual diabetic eye exams than white patients, according to a recent Northwestern Medicine study.

      Source: news.feinberg.northwestern.edu
      Categories: General Medicine News, Ophthalmology
      Tweet Tweets with this article
      • Profile photo of 	NatEyeInstitute
        NatEyeInstitute

        An #NEIFunded study out of @NorthwesternMed found that factors like race or where someone lives can make it less likely for them to get the care they need for diabetic retinopathy, a vision-threatening complication of diabetes. Read more here: https://t.co/JG2ZcDvrsW https://t.co/iNxoPQqrrr

    • Mashup Score: 19
      Molecular Profiling May Improve Meningioma Decisionmaking - 10 month(s) ago

      Investigators have demonstrated how molecular profiling of tumors can be used to help predict treatment response and survival in patients with meningiomas, the most common type of primary brain tumor, according to a recent study published in Nature Medicine.

      Source: news.feinberg.northwestern.edu
      Categories: General Medicine News, Oncologists1
      Tweet Tweets with this article
      • Profile photo of 	LurieCancer
        LurieCancer

        Molecular profiling can be used to improve clinical decision-making and outcomes for patients with #meningioma, according to @CraigHorbinski, co-author of a recent study in @NatureMedicine. https://t.co/IMgdihc2kR via @NUFeinbergMed #neuropath https://t.co/psJHWQG0P1

    • Mashup Score: 8
      Combination Treatment Improves Survival in Advanced Prostate Cancer with Genetic Mutations - 10 month(s) ago

      A combination therapy improved progression-free survival in patients with metastatic castration-resistant prostate cancer with genetic mutations compared to either therapy alone or sequentially, according to results from a Northwestern Medicine-led clinical trial.

      Source: news.feinberg.northwestern.edu
      Categories: General Medicine News, Oncologists1
      Tweet Tweets with this article
      • Profile photo of 	LurieCancer
        LurieCancer

        Abiraterone/prednisone + olaparib improved progression-free survival in patients with advanced #prostatecancer with distinct genetic mutations, per a @ThePCCTC-managed multi-center clinical trial led by Maha Hussain, MD, of @LurieCancer in @CCR_AACR. https://t.co/C2uZQNmFur… https://t.co/RcLhSXruan https://t.co/JyQpW9mRtj

    • Mashup Score: 7
      Oncoprotein Activity Increases Prostate Cancer Progression - 11 month(s) ago

      Investigators have discovered that aberrant activation of a specific oncoprotein drives key tumor promoting changes in the prostate tissue microenvironment during cancer progression, according to a Northwestern Medicine study published in Nature Communications.

      Source: news.feinberg.northwestern.edu
      Categories: General Medicine News, Oncologists1
      Tweet Tweets with this article
      • Profile photo of 	LurieCancer
        LurieCancer

        Aberrant activation of a specific oncoprotein drives key changes in the prostate tissue microenvironment during #prostatecancer progression, according to a study in @NatureComms, co-led by @MindyKimGraham, PhD. https://t.co/JBidOE7A4U via @NUFeinbergMed

    • Mashup Score: 3
      Developing New Methods for Targeted Protein Degradation - 11 month(s) ago

      Northwestern Medicine scientists have developed a new, more precise method to target proteins implicated in certain types of cancer, according to a study published in Nature Chemical Biology.

      Source: news.feinberg.northwestern.edu
      Categories: General Medicine News, Oncologists1
      Tweet Tweets with this article
      • Profile photo of 	LurieCancer
        LurieCancer

        Lurie Cancer Center scientists at @NorthwesternMed have developed a new, more precise method to target proteins implicated in certain types of #cancer, according to a study published in @nchembio. https://t.co/WS9IeGjIHr via @NUFeinbergMed #TPD

    • Mashup Score: 6
      Study Finds Noncoding RNAs Dysregulated in Several Human Cancers - 11 month(s) ago

      Northwestern Medicine scientists have discovered new insights into the production and regulation of an emerging class of noncoding RNAs in three major types of cancer, according to findings published in Science Advances.

      Source: news.feinberg.northwestern.edu
      Categories: General Medicine News, Oncologists1
      Tweet Tweets with this article
      • Profile photo of 	LurieCancer
        LurieCancer

        .@LurieCancer scientists at @NorthwesternMed have have found new insights into noncoding #RNAs and how changes in their signatures diversify and modulate the transcriptome of three major types of #cancer, according to findings from @LauberthLab. https://t.co/Op31TNiKY4…

    Load More
    ASCO 2025

    Advertisement

    Advertisement

    MashupMD
    © 2025 - Mashup Media LLC
    • Terms of Use
    • Privacy Policy
    • Cookie Settings